IS ELECTRICAL STIMULATION A
DRUG? IS BIOFEEDBACK A DRUG?
IS ELECTRICAL STIMULATION A
BEHAVIORAL THERAPY?
J. D. Perry, Petaluma,
California
Abstract
AHCPR, the federal Agency for
Health Care Policy and Research, has assigned electrical stimulation therapy
for incontinence to the category “behavioral therapies.” This gives electrical stimulation the same
classification as biofeedback. The
author challenges this classification, and argues for essential differences
between behavior therapy, a learning oriented intervention, and electrical
stimulation, which actively impacts on a passive patient. In some ways,
electrical stimulation is more accurately construed as a type of pharmaceutical,
or in a unique fourth category of its own.
He argues that the personal involvement of the teacher and student are
critical to education, behavior therapy, and biofeedback, whereas the person of
the therapist and patient are irrelevant for electrical stimulation.
The
AHCPR Guideline on Urinary Incontinence in Adults (1992, 1996) assumed that all
treatments for incontinence could be divided into just "three major
categories": Behavioral, Pharmacologic, and Surgical. No formal definitions were provided for
these categories, but it is clear that AHCPR assumed that Surgical Treatments
include all surgical interventions, Pharmacologic Treatments include all
medications, and, by default, everything else was classified as a
"Behavioral Treatment". Since
electrical stimulation did not involve medication, it was classified in
"Other-behavioral therapies". It is our contention, and will be
shown, that as a result of this arbitrary classification, considerable
confusion has resulted in the analysis of electrical stimulation research and
many misleading conclusions have been drawn by well-meaning researchers and
practitioners alike.
WHAT
IS BEHAVIORAL THERAPY? A leading
textbook in the field defines behavioral therapy and behavioral medicine as
outgrowths of behavior modification, which taught that "maladaptive
behaviors" were "learned" and thus could be
"unlearned". Specifically,
"Behavioral medicine focuses on applications of learning theories to
medical disorders and other health-related topics." (Schwartz, 1995, p. 6). It is central to the concept of behavioral
therapy that a person, if willing and motivated, can be taught to modify his or
her behavior to enhance physical health.
Common examples include smoking cessation and weight control programs,
and it is obvious that a person has to "want to change" or the therapy
-- however clever -- will have no effect.
WHAT
IS PHARMACOLOGY? All definitions of
pharmacologic ingredients are based on the premise that there is an active
"agent" (chemical) in the medication itself which produces one or
more specific effects in the patient, absolutely without regard to the
patient's will or desire to obtain that effect. In research, trials are controlled so that any patient-related
behavior, expectations, or motivations are ascribed to "placebo
effects" and are compared, favorably or otherwise, to the action of the
"drug itself". A drug is only
approved by the FDA for marketing if it can be shown to produce changes without
regard to patient-related variables. A
drug which only works for those patients who "try hard" and
"believe in it" can not be sold.
Biofeedback,
now some 30 years old, is widely recognized as one of the most technologically
sophisticated forms of behavioral therapy.
It involves the monitoring, amplification and display of certain bodily
functions in order to permit the patient to learn to have more conscious
control over those functions and thus enhance their own health. EMG Biofeedback has been used in the
rehabilitation of pelvic muscles for over 20 years. In classic simplicity,
biofeedback involves (1) an electronic device, (2) connecting wires, and (3)
sensors attached to the body. At first
glance, there appears to be a superficial similarity between electrical
stimulation devices and biofeedback devices -- indeed, many are made by the
same manufacturers, and may even include the same external boxes, wires and
sensors.
But
the electronics are quite different, and any similarity is only
superficial. In biofeedback, all
electrical currents travel away from the patient into the box. In electrical stimulation, all electrical
currents travel from the box into the patient. This distinction is as important as the
difference between making a deposit into your bank account and writing a check
on the account, as many of us have discovered the hard way.
In
the early days of electrical stimulation research, subjects were often
instructed to "make a Kegel contraction" when they felt the twitch of
stimulation. In this model it became
impossible to separate the effects of the stimulator from the effects of the
Kegel exercises done by the patient, and the stimulator could not be described
as anything more than an over-priced metronome. More recently, in an effort to provide better
"controlled" research, patients have instructed to remain totally
passive. Recent advertisements for a
well funded magnetically coupled form of electrical stimulation show a woman
seated in a specially equipped chair reading a magazine while the stimulator
"fixes" her weak pelvic muscles.
No attention, volition, cooperation, motivation or even activity is
required on the patient's part.
Considered at this level, the differences between biofeedback and other
behavioral therapies on the one hand, and electrical stimulation on the other,
are decisive; electrical stimulation is not a form of behavior therapy.
But
at a deeper level of analysis, it is well known that the mechanism by which
electrical stimulation operates is ultimately, if not initially, very similar
to medications. Many incontinence drugs
achieve their effect by enhancing synaptic transmission of electro-chemical
impulses to the pelvic muscles.
Stimulators accomplish the same effect by injecting a stronger than
natural signal, instead.
Because
of the many differences between stimulation and biofeedback, and the basic
similarities between stimulation and medication, it is proposed that
stimulation devices be classified, for purposes of this discussion, as
pharmaceuticals, rather than behavioral therapies. And as a consequence of this reclassification, stimulators should
be subject to the same rigid experimental controls and research requirements as
other drugs that rely on the presence of an "active agent" in the
treatment.
One
result of moving electrical stimulation out of the behavioral category is that
it leaves behind a much more consistent and coherent group of therapies. In the words of the 1992 Guideline,
"All behavioral techniques involve educating the patient and providing
positive reinforcement for effort and progress (p. 27)." In addition, the Guideline states that
"These techniques . . . require personal (and caregiver) involvement and
continued practice. If motivated, most
people . . . show improvement . . .(p. 28)." [Note that none of these requirements applied to electrical
stimulation, anyway.]
The
Guideline also discusses various limitations "that determine the
effectiveness of behavioral interventions". But given the emphasis on "learning" and
"motivation", it is noteworthy that when actually reviewing research
there is absolutely no discussion about the skill, experience or expertise of
the person who teaches these techniques and attempts to encourage high levels
of motivation in the patient. Is it not
likely that some teachers are better than others? That some methods are better than others? That some trainers are more
"motivating" than others? If
behavioral therapies were a sub-category of pharmaceuticals, these questions
would be considered inappropriate. The
effectiveness of a medication must be entirely independent of the personal
characteristics, including expertise and experience, of the medication
dispenser. But that is not true of
teachers. Almost everyone remembers
with fondness and appreciation certain teachers who, by virtue of personal
characteristics, stand out as having made a difference in our lives.
It
is important to notice that the personal characteristics of the dispenser were
considered important in the third treatment category, Surgery. The Guideline states quite clearly that
"Success of any surgical procedure depends on operator
expertise…Prospective comparisons often include different surgeons with
different degrees of experience and expertise." (1992, p. 48). Why, we
may ask, is "operator expertise" considered a valid question for
surgeons but not for teachers? It does
not make sense to allow for surgeon's skills and not to consider teacher's
skills.
Surgeons
have specialized training, and must demonstrate specific skills to practice at
all. And in every state in the Union, public school teachers must be certified to
meet minimum state requirements for teaching skills. Why should we assume that skill level is not important in
behavioral therapies? The Biofeedback
Certification Institute of America has been certifying competence in
biofeedback for nearly two decades, and many nurses and physical therapists are
certified and use the initials "BCIA-C" after their names.
Yet
unlike surgeons, the competence of teachers of behavioral therapies is seldom
examined. In published research the
personality and motivational capacity of the teacher has often been overlook or
downgraded. Berghmans et al (1996)
actually boasts that biofeedback patients were treated the same as controls:
"The physiotherapist gives the treatments in such a way that no difference
is noticeable in the approach of the two interventions (p. 40)." Burns (1993) also reported extensive efforts
to provide exactly equivalent therapist contact to both experimental and
control group subjects. While
appropriate in drug research designs, such depersonalization of teaching can
hardly be justified by any theory of education or motivation.
CONCLUSION: Electrical stimulation may be considered a
variant of pharmacology for research purposes, and personal qualities of the
dispensing staff are necessarily irrelevant.
In contrast, for incontinence research involving either surgeons or
teachers, issues of training, experience, and expertise are of major
significance and should be fully disclosed and discussed.
References
Berghmans LCM, Frederiks
CMA, de Bie RA, Weil EHJ, Smetts LWH, Janknegt RA (1996) Efficacy of
biofeedback, when included with standard pelvic floor training, for genuine
stress incontinence. Neurology and
Urodynamics, 15:37-52.
Burns PA, Pranikoff K,
Nochajski TH, Hadley EL, Levy KJ, Ory MG (1993): A comparison of effectiveness
of biofeedback and pelvic muscle exercise treatment of stress incontinence in
older community-dwelling women. J Gerontol Medical Sciences 48: 167-174.
Fantl, JA, Newman, DK, &
Colling, J (1996). Urinary
Incontinence in Adults: Acute and
Chronic Management: Clinical Practice
Guideline. Rockville: U.S. Department of Health and Human
Services. Public Health Service, Agency for Health Care Policy and Research.
AHCPR Publication No. 96-0682.
Schwartz M. (Ed.)
Biofeedback: A Practitioner's Guide, Second Edition. New York, London: Guilford Press.
Urinary Incontinence
Guideline Panel (1992). Urinary
Incontinence in Adults: Clinical Practice Guideline. Rockville, MD: Agency for Health Care Policy
and Research, Public Health Service, U.S. Department of Health and Human
Services. AHCPR Pub. No. 92-0038.